Sign in
Taking people in United StatesPhase 1

Inflammatory Challenge and Fear

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1
People taking part
288 people, planned
Started
28 Mar 2025
Expected to end
Nov 2028
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Typhoid VI Polysaccharide Vaccine Injectable Solution
  • Saline Placebo (0.5mL injection)
Record updated
21 September 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • All Subjects:
  • Aged 18-65 years old
  • Trauma Exposed
  • Current PTSD/No history of PTSD

Who cannot take part

  • Contraindications to typhoid vaccine
  • Conditions associated with inflammation
  • Pregnancy or plans to become pregnant in next three months

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in United States.

  • San Francisco VA Health Care SystemSan Francisco, United StatesContact: Aoife O'Donovan, PhDTaking people

About the trial

What the trial wants to find out

The goal of this study is to learn if short-term changes in the immune system alter how we process information and experience fear. The main questions it aims to answer are:

Read full original descriptionShow less

Do people who receive typhoid vaccine respond differently than those who receive a placebo saline vaccine? Do people who receive typhoid vaccine experience changes in how they think and feel?

Participants will:

Attend four appointments at the San Francisco VA Health Care System;

Receive typhoid vaccine or placebo at one of the visits;

Have their physiological responding measured while listening to sounds;

Complete questionnaires and psychological tests.

The 2 groups in the trial

  • Polysaccharide typhoid vaccineTreatment being tested

    Participants in this condition will receive an injection of 0.5ml Salmonella typhi capsular polysaccharide vaccine (Sanofi Pasteur, SA), which contains 25μg of purified Vi polysaccharide in a colorless isotonic phosphate buffered saline (pH 7±0.3), 4.150mg of sodium chloride, 0.065mg of disodium phosphate, 0.023mg of monosodium phosphate and 0.5ml of sterile water for injection.

    Treatment: Typhoid VI Polysaccharide Vaccine Injectable Solution

  • Saline Placebo ArmPlacebo, for comparison

    Participants in this condition will receive and injection of 0.5ml of saline.

    Treatment: Saline Placebo (0.5mL injection)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Inflammatory Challenge and Fear Extinction: A Model to Enhance Understanding of Posttraumatic Stress Disorder
Criteria questions
Built from NCT06630884, who can take part
Record updated
21 September 2026